Conquering Diseases

Study Of An Investigational Drug For Her2-Positive Metastatic Breast Cancer


Seeking men and women with HER2-positive breast cancer that has spread to other parts of the body (metastatic) for a study of an investigational drug.


We are comparing whether adding an investigational drug to the usual treatment will lengthen the time that participants are able to live with their cancer. Participants in this study will either get the investigational drug or a placebo (looks like the investigational drug but doesn't contain any medicine) in addition to the usual treatment for HER2-Positive Metastatic Breast Cancer.

What we're hoping for

Compare the investigational drug to the usual treatment for metastatic breast cancer that is HER2 positive. We want to see if using the investigational drug is better, the same or worse than the usual treatment.

Additional Information Identifier: NCT03199885

 Principal Investigator

Madhavi  Toke, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655